New Century Advisors’s Thermo Fisher Scientific TMO Stock Holding History

New Century Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$183K	Hold	360	–	–	0.22%	50
2022 Q2	$196K	Hold	360	–	–	0.22%	49
2022 Q1	$213K	Hold	360	–	–	0.18%	65
2021 Q4	$240K	Buy	+360	New	+$225K	0.23%	66

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

New Century Advisors's TMO Position: Q3 2022 in Review

New Century Advisors held its Thermo Fisher Scientific (TMO) position steady in Q3 2022 at 360 shares worth $183K. The position accounts for 0.22% of the portfolio, ranked #50.

New Century Advisors first reported a position in TMO in Q4 2021 and has held it in 4 quarters since. The position peaked at $240K in Q4 2021. 2,267 funds tracked by Wall St. Rank hold TMO as of Q3 2022.

New Century Advisors held 360 shares of Thermo Fisher Scientific worth $183K as of Q3 2022.
New Century Advisors left its Thermo Fisher Scientific share count unchanged in Q3 2022.
Thermo Fisher Scientific made up 0.22% of New Century Advisors's portfolio in Q3 2022, its #50 holding.
New Century Advisors first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 4 quarters since.
New Century Advisors's Thermo Fisher Scientific position peaked at $240K in Q4 2021.
2,267 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2022.

Based on New Century Advisors's 13F filing for Q3 2022, filed 13 Oct 2022.